Friday, February 17, 2012: 8:30 AM
Room 220 (VCC West Building)
Dr. Huntsman will provide examples of how next generation sequencing technology has already changed our understanding of several diseases and is already a major source of novel biomarkers to personalize disease control. Novel somatic biomarkers for ovarien cancer and disease susceptibility alleles will be discussed in the context of standard discovery techniques and today’s approach to laboratory medicine.
See more of: Personalized Medicine: Improving Health Outcomes Through Research
See more of: Health
See more of: Symposia
See more of: Health
See more of: Symposia